Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended				9 Months Ended
	Mar. 31, 2023	Jan. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			$ 556,243	$ 520,406			$ 1,627,351	$ 1,536,710
Government grant income				4			184	6,765
Less: Interest income			(5,360)	(5,963)			(16,802)	(16,950)
Healthpeak’s share of unconsolidated joint venture total revenues			23,743	22,350			69,943	62,804
Healthpeak’s share of unconsolidated joint venture government grant income				183			229	831
Noncontrolling interests’ share of consolidated joint venture total revenues			(8,889)	(9,023)			(26,813)	(26,906)
Operating expenses			(232,734)	(220,208)			(677,659)	(642,499)
Healthpeak’s share of unconsolidated joint venture operating expenses			(16,698)	(15,689)			(48,944)	(45,460)
Noncontrolling interests’ share of consolidated joint venture operating expenses			2,507	2,579			7,585	7,945
Adjustments to NOI			(13,416)	(19,224)			(37,729)	(61,431)
Adjusted NOI			305,396	275,415			897,345	821,809
Plus: Adjustments to NOI			13,416	19,224			37,729	61,431
Interest income			5,360	5,963			16,802	16,950
Interest expense			(50,510)	(44,078)			(147,547)	(123,531)
Depreciation and amortization			(184,559)	(173,190)			(561,357)	(531,412)
General and administrative			(23,093)	(24,549)			(73,576)	(73,161)
Transaction costs			(36)	(728)			(3,098)	(1,636)
Impairments and loan loss reserves, net			550	(3,407)			156	(3,678)
Gain (loss) on sales of real estate, net			0	(4,149)			86,463	10,047
Other income (expense), net			1,481	305,678			4,208	326,855
Less: Government grant income				(4)			(184)	(6,765)
Less: Healthpeak’s share of unconsolidated joint venture NOI			(7,045)	(6,844)			(21,228)	(18,175)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			6,382	6,444			19,228	18,961
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			67,342	355,775			254,941	497,695
Income tax benefit (expense)			(787)	3,834			(2,225)	3,775
Equity income (loss) from unconsolidated joint ventures			2,101	(325)			6,646	2,141
Income (loss) from continuing operations			68,656	359,284			259,362	503,611
Income (loss) from discontinued operations			0	(1,298)			0	2,011
Net income (loss)			68,656	357,986			259,362	505,622
Corporate Non-segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			0	0			0	0
Government grant income				0			0	0
Less: Interest income			0	0			0	0
Healthpeak’s share of unconsolidated joint venture total revenues			0	0			0	0
Healthpeak’s share of unconsolidated joint venture government grant income				0			0	0
Noncontrolling interests’ share of consolidated joint venture total revenues			0	0			0	0
Operating expenses			0	0			0	0
Healthpeak’s share of unconsolidated joint venture operating expenses			0	0			0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses			0	0			0	0
Adjustments to NOI			0	0			0	0
Adjusted NOI			0	0			0	0
Plus: Adjustments to NOI			0	0			0	0
Interest income			0	0			0	0
Interest expense			(46,733)	(40,227)			(136,286)	(112,971)
Depreciation and amortization			0	0			0	0
General and administrative			(23,093)	(24,549)			(73,576)	(73,161)
Transaction costs			(47)	0			(2,306)	(443)
Impairments and loan loss reserves, net			0	0			0	0
Gain (loss) on sales of real estate, net				0			0	0
Other income (expense), net			1,203	698			3,502	2,527
Less: Government grant income				0			0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			0	0			0	0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0	0			0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			(68,670)	(64,078)			(208,666)	(184,048)
Income tax benefit (expense)			(787)	3,834			(2,225)	3,775
Equity income (loss) from unconsolidated joint ventures			0	0			0	0
Income (loss) from continuing operations			(69,457)	(60,244)			(210,891)	(180,273)
Income (loss) from discontinued operations			0	(1,298)			0	2,011
Net income (loss)			(69,457)	(61,542)			(210,891)	(178,262)
Lab
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		$ 60,000				$ 4,000
Lab | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			226,059	207,795			654,829	609,620
Government grant income				0			0	0
Less: Interest income			0	0			0	0
Healthpeak’s share of unconsolidated joint venture total revenues			2,425	2,938			6,519	5,637
Healthpeak’s share of unconsolidated joint venture government grant income				0			0	0
Noncontrolling interests’ share of consolidated joint venture total revenues			(154)	(55)			(449)	(174)
Operating expenses			(60,268)	(55,162)			(172,666)	(152,796)
Healthpeak’s share of unconsolidated joint venture operating expenses			(958)	(777)			(2,987)	(1,744)
Noncontrolling interests’ share of consolidated joint venture operating expenses			33	21			108	59
Adjustments to NOI			(9,842)	(15,221)			(25,618)	(50,977)
Adjusted NOI			157,295	139,539			459,736	409,625
Plus: Adjustments to NOI			9,842	15,221			25,618	50,977
Interest income			0	0			0	0
Interest expense			0	0			0	0
Depreciation and amortization			(78,646)	(70,141)			(247,463)	(227,952)
General and administrative			0	0			0	0
Transaction costs			(51)	(40)			(209)	(367)
Impairments and loan loss reserves, net			0	0			0	0
Gain (loss) on sales of real estate, net				0			60,498	3,856
Other income (expense), net			(1)	311,912			1	311,932
Less: Government grant income				0			0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(1,467)	(2,161)			(3,532)	(3,893)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			121	34			341	115
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			87,093	394,364			294,990	544,293
Income tax benefit (expense)			0	0			0	0
Equity income (loss) from unconsolidated joint ventures			1,244	(877)			3,155	237
Income (loss) from continuing operations			88,337	393,487			298,145	544,530
Income (loss) from discontinued operations			0	0			0	0
Net income (loss)			88,337	393,487			298,145	544,530
Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net	$ 21,000			1,000	$ 10,000
Outpatient Medical | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			191,016	184,506			564,644	541,078
Government grant income				0			0	0
Less: Interest income			0	0			0	0
Healthpeak’s share of unconsolidated joint venture total revenues			746	756			2,245	2,249
Healthpeak’s share of unconsolidated joint venture government grant income				0			0	0
Noncontrolling interests’ share of consolidated joint venture total revenues			(8,735)	(8,968)			(26,364)	(26,732)
Operating expenses			(67,693)	(64,782)			(197,442)	(189,274)
Healthpeak’s share of unconsolidated joint venture operating expenses			(301)	(313)			(895)	(912)
Noncontrolling interests’ share of consolidated joint venture operating expenses			2,474	2,558			7,477	7,886
Adjustments to NOI			(3,547)	(4,079)			(11,373)	(10,574)
Adjusted NOI			113,960	109,678			338,292	323,721
Plus: Adjustments to NOI			3,547	4,079			11,373	10,574
Interest income			0	0			0	0
Interest expense			(1,947)	(1,964)			(5,791)	(4,931)
Depreciation and amortization			(72,736)	(70,917)			(215,617)	(207,563)
General and administrative			0	0			0	0
Transaction costs			(23)	(94)			(171)	(168)
Impairments and loan loss reserves, net			0	0			0	0
Gain (loss) on sales of real estate, net				554			21,312	10,894
Other income (expense), net			78	154			517	12,354
Less: Government grant income				0			0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(445)	(443)			(1,350)	(1,337)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			6,261	6,410			18,887	18,846
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			48,695	47,457			167,452	162,390
Income tax benefit (expense)			0	0			0	0
Equity income (loss) from unconsolidated joint ventures			211	206			585	617
Income (loss) from continuing operations			48,906	47,663			168,037	163,007
Income (loss) from discontinued operations			0	0			0	0
Net income (loss)			48,906	47,663			168,037	163,007
CCRC | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			133,808	122,142			391,076	369,062
Government grant income				4			184	6,765
Less: Interest income			0	0			0	0
Healthpeak’s share of unconsolidated joint venture total revenues			0	0			0	0
Healthpeak’s share of unconsolidated joint venture government grant income				0			0	334
Noncontrolling interests’ share of consolidated joint venture total revenues			0	0			0	0
Operating expenses			(104,773)	(100,264)			(307,551)	(300,429)
Healthpeak’s share of unconsolidated joint venture operating expenses			0	0			0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses			0	0			0	0
Adjustments to NOI			0	0			(679)	0
Adjusted NOI			29,035	21,882			83,030	75,732
Plus: Adjustments to NOI			0	0			679	0
Interest income			0	0			0	0
Interest expense			(1,830)	(1,887)			(5,470)	(5,629)
Depreciation and amortization			(33,177)	(32,132)			(98,277)	(95,897)
General and administrative			0	0			0	0
Transaction costs			85	(594)			(412)	(658)
Impairments and loan loss reserves, net			0	0			0	0
Gain (loss) on sales of real estate, net				0			0	0
Other income (expense), net			254	(7,086)			260	55
Less: Government grant income				(4)			(184)	(6,765)
Less: Healthpeak’s share of unconsolidated joint venture NOI			0	0			0	(334)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0	0			0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			(5,633)	(19,821)			(20,374)	(33,496)
Income tax benefit (expense)			0	0			0	0
Equity income (loss) from unconsolidated joint ventures			0	0			0	539
Income (loss) from continuing operations			(5,633)	(19,821)			(20,374)	(32,957)
Income (loss) from discontinued operations			0	0			0	0
Net income (loss)			(5,633)	(19,821)			(20,374)	(32,957)
Other Non-reportable | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			5,360	5,963			16,802	16,950
Government grant income				0			0	0
Less: Interest income			(5,360)	(5,963)			(16,802)	(16,950)
Healthpeak’s share of unconsolidated joint venture total revenues			20,572	18,656			61,179	54,918
Healthpeak’s share of unconsolidated joint venture government grant income				183			229	497
Noncontrolling interests’ share of consolidated joint venture total revenues			0	0			0	0
Operating expenses			0	0			0	0
Healthpeak’s share of unconsolidated joint venture operating expenses			(15,439)	(14,599)			(45,062)	(42,804)
Noncontrolling interests’ share of consolidated joint venture operating expenses			0	0			0	0
Adjustments to NOI			(27)	76			(59)	120
Adjusted NOI			5,106	4,316			16,287	12,731
Plus: Adjustments to NOI			27	(76)			59	(120)
Interest income			5,360	5,963			16,802	16,950
Interest expense			0	0			0	0
Depreciation and amortization			0	0			0	0
General and administrative			0	0			0	0
Transaction costs			0	0			0	0
Impairments and loan loss reserves, net			550	(3,407)			156	(3,678)
Gain (loss) on sales of real estate, net				(4,703)			4,653	(4,703)
Other income (expense), net			(53)	0			(72)	(13)
Less: Government grant income				0			0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(5,133)	(4,240)			(16,346)	(12,611)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0	0			0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			5,857	(2,147)			21,539	8,556
Income tax benefit (expense)			0	0			0	0
Equity income (loss) from unconsolidated joint ventures			646	346			2,906	748
Income (loss) from continuing operations			6,503	(1,801)			24,445	9,304
Income (loss) from discontinued operations			0	0			0	0
Net income (loss)			$ 6,503	$ (1,801)			$ 24,445	$ 9,304